Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Merger with CLS Labs (Details) - Business Acquisition, Pro Forma Information

v3.3.0.814
Note 3 - Merger with CLS Labs (Details) - Business Acquisition, Pro Forma Information
3 Months Ended
Aug. 31, 2014
USD ($)
$ / shares
shares
Business Acquisition, Pro Forma Information [Abstract]  
Total revenue $ 0
Net loss attributable to CLS Holdings USA, Inc. $ (128,657)
Basic net income (loss) per common share | $ / shares $ (0.01)
Diluted net income (loss) per common share | $ / shares $ (0.01)
Weighted average shares - basic | shares 15,000,000
Weighted average shares - diluted | shares 15,000,000